Cardiabet Criticare Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 5.74 M
as on 04-07-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -300.33%
(FY 2023)
- Ebitda -10547.58%
(FY 2023)
- Net Worth -45.17%
(FY 2023)
- Total Assets -45.14%
(FY 2023)
About Cardiabet Criticare
The Corporate was formerly known as Soham Business Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.74 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Jasuja and Neelam Seth serve as directors at the Company.
- CIN/LLPIN
U74900DL2009PTC194936
- Company No.
194936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cardiabet Criticare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Jasuja  | Director | 03-Sep-2022 | Current |
| Neelam Seth | Director | 13-Aug-2018 | Current |
Financial Performance of Cardiabet Criticare.
Cardiabet Criticare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 300.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardiabet Criticare?
In 2022, Cardiabet Criticare had a promoter holding of 10.30% and a public holding of 89.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sonika Life Sciences LimitedActive 13 years 7 monthsVishal Jasuja and Neelam Seth are mutual person
Ridhaan Packing Materials Private LimitedActive 17 years 7 monthsVishal Jasuja and Neelam Seth are mutual person
- Seth Property Developers LimitedActive 20 years 3 months
Vishal Jasuja and Neelam Seth are mutual person
- Seth Capital Services LimitedActive 16 years 4 months
Vishal Jasuja and Neelam Seth are mutual person
- Seth Equities Private LimitedActive 16 years 10 months
Vishal Jasuja and Neelam Seth are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cardiabet Criticare?
Unlock and access historical data on people associated with Cardiabet Criticare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardiabet Criticare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardiabet Criticare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
